MetaCap

DataMeds AI (MEDS) vs Nu Skin Enterprises (NUS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.

Summary

Nu Skin Enterprises is the larger company by market cap ($232.2 million vs $9.3 million), about 24.9 times the size. Nu Skin Enterprises pays a dividend yielding 5.03%, while DataMeds AI does not currently pay one.

Summary generated from market data by MetaCap's automated system. Methodology

Head-to-head

MEDS versus NUS key metrics
MetricMEDSNUS
Share price$3.29$4.77
Market cap$9.32M$232.19M
1-day change+14.24%-0.63%
YTD return—-50.10%
1-year return—-56.80%
5-year return—-88.30%
Forward P/E—4.11
EPS (TTM)$-46.68$-4.51
Dividend yield0.00%5.03%
Annual dividend$0.00$0.24
52-week high$73.00$11.67
52-week low$0.823$4.45
Distance from 52-week high-95.49%-59.13%
Analyst consensus—none
Avg. price target upside—+167.71%
Average volume5.82M555.83K
Shares outstanding2.83M48.68M
Employees—2,800
SectorHealth CareHealth Care
IndustryOther PharmaceuticalsOther Pharmaceuticals

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Nu Skin Enterprises is about 24.9 times larger than DataMeds AI by market value ($232.19M vs $9.32M).
  • Nu Skin Enterprises offers a meaningfully higher dividend yield (5.03% vs 0.00%).

About Nu Skin Enterprises

NUS stock →

Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa, ageLOC LumiSpa iO, and Nu Skin RenuSpa iO; ageLOC TruFace and ageLOC LumiSpa cleansers and devices; Prysm iO, a data-enabled wellness device; and Nutricentials beauty and Beauty Focus wellness brands.

Health Care · Other Pharmaceuticals · 2,800 employees

MEDS vs NUS FAQ

Which is bigger, DataMeds AI or Nu Skin Enterprises?

Nu Skin Enterprises (NUS) is larger, with a market capitalization of $232.19M compared with $9.32M for DataMeds AI (MEDS).

Which pays a higher dividend, DataMeds AI or Nu Skin Enterprises?

Nu Skin Enterprises pays a dividend yielding 5.03%, while DataMeds AI does not currently pay a regular dividend.

Are DataMeds AI and Nu Skin Enterprises in the same industry?

Yes. Both are classified in the Other Pharmaceuticals industry within the Health Care sector.

More comparisons